Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Genetics|September 19, 2024
Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort studyMykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, et al.
Frontiers in Microbiology|May 12, 2025
Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver diseaseMykhailo Buchynskyi, Iryna Kamyshna, Iryna Halabitska, et al.
Journal of Neurochemistry|January 5, 2026
Discovery and Characterization of Novel Spirotriazoloquinazolines as Potential Neuroprotectors: Synthesis, Computational Screening, and Preliminary In Vivo EvaluationKostiantyn Shabelnyk, Lyudmyla Antypenko, Natalia Bohdan, et al.
Virology Journal|July 23, 2025
Extracellular DNA, hyaluronic acid, HIF pathways, and LncRNAs as predictive biomarkers of severe COVID-19Evgen Dubrovskyi, Tetiana Drevytska, Alla Portnychenko, et al.
Viruses|March 26, 2022
Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged SwordPavlo Petakh, Iryna Kamyshna, Andriy Nykyforuk, et al.
Virology Journal|May 25, 2026
Standardizing antiviral response metrics for mono- and combination therapies in acute, chronic and latent viral infectionsPavlo Petakh, Erlend Ravlo, Qiuwei Pan, et al.
Cellular and Molecular Life Sciences : CMLS|November 6, 2025
Towards molecular diagnostics of parental alienationOleksandr Kamyshnyi, Iryna Kamyshna, Pavlo Petakh, et al.
Frontiers in Systems Neuroscience|November 26, 2025
Prospects for nasal delivery of a pharmacologic agent for neuroprotective experimental therapy after prenatal hypoxiaIgor Belenichev, Olena Aliyeva, Nina Bukhtiyarova, et al.
Biomedicines|May 27, 2026
The Influence of Basic Therapy and New Drugs on NO-Dependent Mechanisms of Cardiac Destruction in Chronic Heart FailureIgor Belenichev, Olena Popazova, Olexiy Goncharov, et al.
Frontiers in Endocrinology|October 6, 2025
Future horizons in diabetes treatment: hypoglycemic activity of [1,2,4]triazino[2,3-<i>c</i>]quinazoline derivativesSerhii Trzhetsynskyi, Inna Nosulenko, Anna Kinichenko, et al.
Pageof 7